AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 201 filers reported holding AXSOME THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $27,605,152 | -2.7% | 394,980 | +0.0% | 2.06% | +6.3% |
Q2 2023 | $28,376,364 | +35.1% | 394,884 | +16.0% | 1.94% | +21.6% |
Q1 2023 | $20,997,722 | +35.9% | 340,430 | +70.0% | 1.60% | +18.0% |
Q4 2022 | $15,445,591 | +96.9% | 200,254 | +44.5% | 1.35% | +147.3% |
Q1 2021 | $7,846,000 | -53.6% | 138,571 | -33.2% | 0.55% | -58.1% |
Q4 2020 | $16,901,000 | +26.3% | 207,452 | +10.5% | 1.30% | -9.8% |
Q3 2020 | $13,378,000 | +625.9% | 187,756 | +738.2% | 1.45% | +286.6% |
Q2 2020 | $1,843,000 | -44.9% | 22,401 | -60.6% | 0.37% | -42.5% |
Q1 2020 | $3,342,000 | +159.9% | 56,801 | +356.5% | 0.65% | +393.2% |
Q4 2019 | $1,286,000 | – | 12,443 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 1,132,645 | $37,332,000 | 32.86% |
MORGAN JESS S & CO INC | 113,430 | $3,739,000 | 2.47% |
Fairmount Funds Management LLC | 187,598 | $6,183,000 | 2.25% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 1,423,653 | $46,924,000 | 1.43% |
WMS Partners, LLC | 250,000 | $8,240,000 | 1.21% |
Beck Bode, LLC | 102,127 | $3,366,000 | 0.94% |
RTW INVESTMENTS, LP | 1,616,497 | $53,280,000 | 0.80% |
MPM BioImpact LLC | 110,155 | $3,631,000 | 0.56% |
Endurant Capital Management LP | 52,048 | $1,716,000 | 0.39% |
Bellevue Group AG | 752,945 | $24,817,000 | 0.25% |